133 related articles for article (PubMed ID: 17375403)
1. How should postprandial glycemia be treated?
Charpentier G; Dardari D; Riveline JP
Diabetes Metab; 2006 Sep; 32 Spec No2():2S21-7. PubMed ID: 17375403
[TBL] [Abstract][Full Text] [Related]
2. Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.
Aronoff SL
Postgrad Med; 2017 Mar; 129(2):231-241. PubMed ID: 28118069
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Kimura T; Suzuki J; Ichikawa M; Imagawa M; Sato S; Fujii M; Zenimaru Y; Inaba S; Takahashi S; Konoshita T; Miyamori I
Diabetes Technol Ther; 2012 Jul; 14(7):545-51. PubMed ID: 22519736
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
Fonseca V
Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
[TBL] [Abstract][Full Text] [Related]
5. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
[TBL] [Abstract][Full Text] [Related]
6. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
Yacoub T
Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
[TBL] [Abstract][Full Text] [Related]
7. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
8. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.
Tibaldi J
South Med J; 2009 Jan; 102(1):60-6. PubMed ID: 19077774
[TBL] [Abstract][Full Text] [Related]
9. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
10. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological treatment of postprandial hyperglycemia].
Blickle JF
Diabetes Metab; 2000 Jun; 26 Suppl 2():20-4. PubMed ID: 10975046
[TBL] [Abstract][Full Text] [Related]
12. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
Charpentier G; Riveline JP; Dardari D; Varroud-Vial M
Drugs; 2006; 66(3):273-86. PubMed ID: 16526817
[TBL] [Abstract][Full Text] [Related]
13. Control of postprandial glucose levels with insulin in type 2 diabetes.
Blevins T
Postgrad Med; 2011 Jul; 123(4):135-47. PubMed ID: 21680998
[TBL] [Abstract][Full Text] [Related]
14. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Umpierrez GE; Bailey TS; Carcia D; Shaefer C; Shubrook JH; Skolnik N
J Diabetes; 2018 Feb; 10(2):94-111. PubMed ID: 28581207
[TBL] [Abstract][Full Text] [Related]
15. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.
Dzygalo K; Szypowska A
Eur J Endocrinol; 2014 Apr; 170(4):539-45. PubMed ID: 24412929
[TBL] [Abstract][Full Text] [Related]
16. IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.
Holst JJ; Buse JB; Rodbard HW; Linjawi S; Woo VC; Boesgaard TW; Kvist K; Gough SC
J Diabetes Sci Technol; 2015 Oct; 10(2):389-97. PubMed ID: 26443290
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
Abrahamson MJ
Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824
[TBL] [Abstract][Full Text] [Related]
19. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
20. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
